Debate 1
March 6, 2025, 13:00-14:00 (CET)
What Should We Use As the First-Line Treatment for RA?
b/tsDMARDs: Zoltan Szekanecz
MTX: Andrea Rubbert-Roth
Debate 2
March 6, 2025, 13:00-14:00 (CET)
Are the New Classification Criteria a Step Forward in the Management of Antiphospholipid Syndrome?
Yes: Savino Sciascia
No: Jaume Alijotas-Reig
Debate 3
March 6, 2025, 14:10-15:10 (CET)
LN Treatment: Early Combination vs. Standard Treatment
Early Combination: Ioannis Parodis
Standard Treatment: Laurent Arnaud
Debate 4
March 6, 2025, 14:10-15:10 (CET)
The Use of Medical Cannabis in Rheumatic Pain Management: Valid Option or Unproven treatment?
Valid Option: Howard Amital
Unproven Treatment: Winfried Häuser
Debate 5
March 7, 2025, 9:05-10:05 (CET)
Beyond Physical Examination – How to Approach to RA Management: Joint Ultrasound or Synovial Biopsy?
Joint Ultrasound: Maria-Antonietta D'Agostino
Synovial Biopsy: Felice Rivellese
Debate 6
March 7, 2025, 9:05-10:05 (CET)
Mepolizumab in EGPA: Does One Size Fit All?
Yes: Benjamin Terrier
No: Giacomo Emmi
Debate 7
March 7, 2025, 10:45-11:45 (CET)
TNFi or IL17i for the Slowing the Radiographic Progression in Spondyloarthritis?
TNFi: Mikkel Østergaard
IL17i: Salvatore D'Angelo
Debate 8
March 7, 2025, 10:45-11:45 (CET)
Gut Microbiome in Rheumatic Diseases: Revolutionary or Fake News?
Revolutionary: Francesco Ciccia
Fake News: Zoltan Szekanecz
Debate 9
March 7, 2025, 11:50-12:50 (CET)
CAR-T Cells in Rheumatic Diseases: Game-Changer or Just a Buzz?
Game-Changer: Laura Bucci
Just a Buzz: Marit Stockfelt
Debate 10
March 7, 2025, 11:50-12:50 (CET)
Is Seronegative Sjogren Syndrome a Distinct Clinical Entity? & Should Hydroxychloroquine Be Used in Patients With Sjogren Syndrome?
Yes: Roberto Gerli
No: Athanasios Tzioufas
Debate 11
March 7, 2025, 15:10-16:10 (CET)
Early Biologic Treatment in Systemic Lupus: Necessary or Overemphasized?
Necessary: Mariele Gatto
Overemphasized: Chris Wincup
Debate 12
March 7, 2025, 15:10-16:10 (CET)
Is Hematopoietic Stem Cell Transplantation (Really) a Valid Option for Patients With Systemic Sclerosis?
Yes: Dominique Farge
No: Oliver Distler
Debate 13
March 7, 2025, 16:50-17:50 (CET)
Can We Give Targeted Therapies in Patients With Cancer?
Yes: Eden Sebbag
No: Zoltan Szekanecz
Debate 14
March 7, 2025, 16:50-17:50 (CET)
Are IPAF and UCTD Two Clinical Variants of the Same Systemic Autoimmune Disorder?
Two Clinical Variants: Marco Sebastiani
The Same: Szilvia Szamosi
Debate 15
March 7, 2025, 17:55-18:55 (CET)
Do JAK Inhibitors Aggravate Comorbidities Such As Cardiovascular Disease and Cancer?
Yes: Serena Bugatti
No: Ernest Choy
Debate 16
March 8, 2025, 9:00-10:00 (CET)
Should We Treat preRA/at Risk RA Individuals or Not?
Yes: Andrew Cope
No: György Nagy
Debate 17
March 8, 2025, 9:00-10:00 (CET)
Is It Common To Achieve the T2T Goals in SLE Patients?
Yes: Marta Mosca
No: Anisur Rahman
Debate 18
March 8, 2025, 11:10-12:10 (CET)
Axial Psoriatic Arthritis and axSpA: To Lump or to Split
To Lump: Philippe Sewerin
To Split: Ennio Lubrano
Debate 19
March 8, 2025, 11:10-12:10 (CET)
Should Immunosuppressive Drugs Be Used in All Patients With the Limited Cutaneous Form of SSc?
Yes: Marco Matucci-Cerinic
No: Yannick Allanore
Debate 20
March 8, 2025, 14:30-15:30 (CET)
Is It Safe to Use Low-Dose Glucocorticoids in GCA?
Yes: Francesco Muratore
No: Peter Villiger
Debate 21
March 8, 2025, 14:30-15:30 (CET)
Transition From Psoriasis to Psoriatic Arthritis: Are We Getting Closer?
Yes: Alen Zabotti
No: Dennis McGonagle
